37 participants
Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-06-07
- Start Date:
- 2016-04-13
- Completion:
- 2022-05-25
Conditions
- Lung Adenocarcinoma
- Lung Neoplasms
Interventions
- DRUG
- OTHER